Sold a few shares on Friday's low-volume EOD run-up to $5.65, as I was overweight on the position after adding on the previous dip to $4.75. This one trades very thin! Position is now 8% of portfolio, which I'm more comfortable with given the unknown date for the next catalyst (link back). If it runs again I may take advantage and re-build a position after the next data release.
Careful out there! Biopharma looks to be even more volatile than expected given recent PEOTUS rhetoric. Need to be nimble.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.